BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9195960)

  • 1. A distinct function of STAT proteins in erythropoietin signal transduction.
    Kirito K; Uchida M; Yamada M; Miura Y; Komatsu N
    J Biol Chem; 1997 Jun; 272(26):16507-13. PubMed ID: 9195960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel function of Stat1 and Stat3 proteins in erythropoietin-induced erythroid differentiation of a human leukemia cell line.
    Kirito K; Uchida M; Takatoku M; Nakajima K; Hirano T; Miura Y; Komatsu N
    Blood; 1998 Jul; 92(2):462-71. PubMed ID: 9657745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of both erythroid and megakaryocytic differentiation of a human leukemia cell line, UT-7.
    Miura Y; Kirito K; Komatsu N
    Acta Haematol; 1998; 99(3):180-4. PubMed ID: 9587401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation.
    Kirito K; Nakajima K; Watanabe T; Uchida M; Tanaka M; Ozawa K; Komatsu N
    Blood; 2002 Jan; 99(1):102-10. PubMed ID: 11756159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and/or STAT3 are required for regulation of three distinct classes of immediate early genes.
    Tian SS; Tapley P; Sincich C; Stein RB; Rosen J; Lamb P
    Blood; 1996 Dec; 88(12):4435-44. PubMed ID: 8977235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of both STAT and SRF/TCF to c-fos promoter activation by granulocyte-macrophage colony-stimulating factor.
    Rajotte D; Sadowski HB; Haman A; Gopalbhai K; Meloche S; Liu L; Krystal G; Hoang T
    Blood; 1996 Oct; 88(8):2906-16. PubMed ID: 8874187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the erythropoietin-induced erythroid differentiation by granulocyte-macrophage colony-stimulating factor in the human UT-7 cell line is not due to a negative regulation of the erythropoietin receptor.
    Hermine O; Dubart A; Porteux F; Mayeux P; Titeux M; Dumenil D; Vainchenker W
    Blood; 1996 Mar; 87(5):1746-53. PubMed ID: 8634420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases.
    Haq R; Halupa A; Beattie BK; Mason JM; Zanke BW; Barber DL
    J Biol Chem; 2002 May; 277(19):17359-66. PubMed ID: 11875080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician Education: The Erythropoietin Receptor and Signal Transduction.
    Yoshimura A; Arai K
    Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity.
    Gouilleux F; Pallard C; Dusanter-Fourt I; Wakao H; Haldosen LA; Norstedt G; Levy D; Groner B
    EMBO J; 1995 May; 14(9):2005-13. PubMed ID: 7744007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CrkL with STAT5 in hematopoietic cells stimulated by granulocyte-macrophage colony-stimulating factor or erythropoietin.
    Ota J; Kimura F; Sato K; Wakimoto N; Nakamura Y; Nagata N; Suzu S; Yamada M; Shimamura S; Motoyoshi K
    Biochem Biophys Res Commun; 1998 Nov; 252(3):779-86. PubMed ID: 9837784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation.
    Erickson-Miller CL; Pelus LM; Lord KA
    Stem Cells; 2000; 18(5):366-73. PubMed ID: 11007921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor-activated signaling pathways in human neutrophils. Selective activation of Jak2, Stat3, and Stat5b.
    Al-Shami A; Mahanna W; Naccache PH
    J Biol Chem; 1998 Jan; 273(2):1058-63. PubMed ID: 9422769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unregulated activation of STAT-5, ERK1/2 and c-Fos may contribute to the phenotypic transformation from myelodysplastic syndrome to acute leukaemia.
    Kolonics A; Apáti A; Nahajevszky S; Gáti R; Brózik A; Magócsi M
    Haematologia (Budap); 2001; 31(2):125-38. PubMed ID: 11583024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
    Arcasoy MO; Harris KW; Forget BG
    Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activation of Stat1 and Stat3 in primary erythroleukemia cells.
    Kirito K; Nagashima T; Ozawa K; Komatsu N
    Int J Hematol; 2002 Jan; 75(1):51-4. PubMed ID: 11843291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential constitutive activation between STAT-related proteins and MAP kinase in primary acute myelogenous leukaemia.
    Hayakawa F; Towatari M; Iida H; Wakao H; Kiyoi H; Naoe T; Saito H
    Br J Haematol; 1998 Jun; 101(3):521-8. PubMed ID: 9633897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7.
    Komatsu N; Yamamoto M; Fujita H; Miwa A; Hatake K; Endo T; Okano H; Katsube T; Fukumaki Y; Sassa S
    Blood; 1993 Jul; 82(2):456-64. PubMed ID: 8329702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5.
    Okajima Y; Matsumura I; Nishiura T; Hashimoto K; Yoshida H; Ishikawa J; Wakao H; Yoshimura A; Kanakura Y; Tomiyama Y; Matsuzawa Y
    J Biol Chem; 1998 Sep; 273(36):22877-83. PubMed ID: 9722506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway.
    Okutani Y; Kitanaka A; Tanaka T; Kamano H; Ohnishi H; Kubota Y; Ishida T; Takahara J
    Oncogene; 2001 Oct; 20(45):6643-50. PubMed ID: 11641791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.